Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice

Leucine-rich repeat kinase 2 (LRRK2) is genetically implicated in both familial and sporadic Parkinson's disease (PD). Moreover, LRRK2 has emerged as a compelling therapeutic target for the treatment of PD. Consequently, there is much interest in understanding LRRK2 and its role in PD pathogene...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neurobiol Dis
Prif Awduron: Zhao, Ye, Keshiya, Shikara, Atashrazm, Farzaneh, Gao, Jianqun, Ittner, Lars M., Alessi, Dario R., Halliday, Glenda M., Fu, Yuhong, Dzamko, Nicolas
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Academic Press 2018
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6197399/
https://ncbi.nlm.nih.gov/pubmed/30194047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2018.09.003
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg